Welcome to “JDD February 2026 Issue Highlights,” your quick tour of this month’s Editor’s Picks from the Journal of Drugs in Dermatology, curated by the Next Steps in Derm Team. This issue pairs practical algorithms, novel therapeutics, real‑world effectiveness data, equity analyses, and procedural reports, all with immediate clinical relevance.
Explore this month’s top picks below:
-
- Pentoxifylline as a Steroid‑Sparing Agent in Granuloma Annulare: A Rural Retrospective Study — examines disease extent, treatment response, and comorbidity burden to inform steroid‑sparing care in resource‑limited settings.
-
- Practical Algorithm for Acne Treatment Integrating Skincare and Energy‑Based Devices — a clinician‑ready approach for combining topical care with EBDs to manage acne and its sequelae.
-
- Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex — supports clascoterone 1% as an effective topical option for patients ≥12 years.
-
- Real‑World Evidence of Brodalumab Effectiveness for Psoriasis — registry data position brodalumab as a strong option for treatment‑resistant and difficult subtypes.
-
- ChatGPT and DeepSeek in Dermatologic Practice: Do AI Models Adhere to Psoriasis Guidelines? — evaluates two LLMs for concordance with AAD psoriasis recommendations.
-
- Efficacy and Safety of Cysteamine–Isobionic Amide Complex for Periorbital Hyperpigmentation — objective imaging and PROs assess a novel topical complex.
-
- Clinical Efficacy of Second‑Generation Tetracyclines as First‑Line Systemic Agents for Gingival Lichen Planus — doxycycline and minocycline show efficacy for refractory gingival OLP.
-
- Racial Disparities in US Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome — documents enrollment gaps and urges greater inclusivity.
-
- Laser Therapy for Burn Injuries and Military Considerations — a focused review of laser use in burn care and unique military considerations.
-
- Combination Gentian Violet + TCA for DDEB Ulceration — a case reporting notable ulcer improvement with combination topical therapy.
-
- GLP‑1 Receptor Agonists and Hidradenitis Suppurativa in Overweight/Obese Patients — observational data suggesting potential HS benefit.
-
- Reddit Discourse on Eczema: Misinformation vs Guideline Alignment — analyzes engagement and accuracy relative to 2025 AAD guidance.
-
- Dual IL‑17A/F Blockade for Acrodermatitis Continua of Hallopeau — clinical response to bimekizumab in a neutrophil‑dominant pustular disease.
Find more JDD Issue Highlights here.